- The Quantiferon-TB Gold Plus blood test is designed to detect latent tuberculosis in patients.
- Teva Pharmaceuticals gained approval for the first generic version of Gilead Science’s best-selling HIV drug Truvada.
- Symjepi is a single-dose prefilled syringe of epinephrine intended to treat emergency allergic reactions, including anaphylaxis.
- Mydayis is intended to treat ADHD symptoms in patients thirteen years or older.
- Cotempla is an extended-release orally disintegrating tablet intended to treat ADHD in patients ages 6 to 17 years.
- Baxdela is intended to treat skin and skin structure infections caused by various gram-positive and gram-negative bacteria, including methicillin-resistant Staphylococcus aureus.
- Haegarda is the first self-administered C1 esterase inhibitor subcutaneous injection to prevent swelling attacks in patients with hereditary angiodema.
More articles on supply chain:
Drug manufacturer, distributor shut down for producing unapproved medications
Sanofi CEO on SCOTUS’ biologics ruling: 3 takeaways
Whole Foods acquisition could move Amazon closer to pharmacies
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
